Orphan Therapeutics Accelerator at ASHG 2026

Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website

Orphan Therapeutics Accelerator at ASHG 2026 in Montréal: 1 presentation (1 poster).

OrganizationASHG 2026 Attendance
Orphan Therapeutics Accelerator
Silver Spring, Maryland
1 VP, Partnerships & Innovation
Non-profit
Nonprofit biotech that obtains and funds shelved clinical-stage therapies for ultra-rare diseases. It works with partners to complete development and enable commercial access.
Orphan Therapeutics Accelerator expanded its network to extend development and access pathways for ultra-rare disease therapies.
›
Orphan Therapeutics Accelerator expanded its network to extend development and access pathways for ultra-rare disease therapies.
2026-06 · source
Orphan Therapeutics Accelerator and ASGCT launched CGTxchange, a first-of-its-kind marketplace to reactivate shelved cell and gene therapy programs.
2026-05 · source
AGC Biologics joined Orphan Therapeutics Accelerator's clinical development network as a manufacturing partner for ultra-rare disease therapies.
2026-05 · source
Source: company newsroom
Poster
Thu Oct 22
4:15 pm
CGTxchange: A new hope for stalled clinical-stage cell and gene therapies for rare diseases
Collaborators: University of Massachusetts Chan Medical School
Artificial intelligencePublic healthMolecular therapeuticsGene therapy
Session
Fri Oct 23
1:30 pm

Explore the full ASHG 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Montréal. Leave your work email and we’ll be in touch.

Privacy

Download the full ASHG 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Orphan Therapeutics Accelerator

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction